Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$194.33 - $283.97 $256,709 - $375,124
-1,321 Reduced 25.07%
3,948 $786,000
Q2 2023

Aug 11, 2023

BUY
$223.05 - $302.68 $1.18 Million - $1.59 Million
5,269 New
5,269 $1.5 Million
Q4 2022

Feb 13, 2023

SELL
$204.38 - $296.82 $36,788 - $53,427
-180 Reduced 2.89%
6,047 $1.24 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $739,650 - $1.18 Million
3,789 Added 155.41%
6,227 $1.73 Million
Q2 2022

Aug 12, 2022

SELL
$115.91 - $214.48 $179,892 - $332,872
-1,552 Reduced 38.9%
2,438 $466,000
Q1 2022

May 13, 2022

BUY
$127.96 - $207.36 $282,407 - $457,643
2,207 Added 123.78%
3,990 $827,000
Q4 2021

Feb 11, 2022

SELL
$165.13 - $241.83 $49,208 - $72,065
-298 Reduced 14.32%
1,783 $318,000
Q3 2021

Nov 12, 2021

BUY
$163.99 - $235.57 $341,263 - $490,221
2,081 New
2,081 $428,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.